Articles
A Risk Score to Predict the Absence of Left Ventricular Reverse Remodelling: Implications for the Timing of ICD Implantation in Primary Prevention
Citation:
European Cardiology Review 2017;12(2):99.
Nobiletin a Citrus Flavonoid, Exerts Additional Effects with Angiotensin II Receptor Blocker on Systolic Function in Salt-sensitive Dahl Rats
Citation:
European Cardiology Review 2017;12(2):92.
5-Year Outcomes After Implementation of Optimal Medical Therapy in General Practice Using Liaison Critical Pathway for Secondary Prevention of Coronary Artery Disease: An Observational Study
Citation:
European Cardiology Review 2017;12(2):98.
Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker
Citation:
European Cardiology Review 2017;12(2):96.
Does Angiotensin Receptor Neprilysin Inhibitor (ARNI) Improve Functional Capacity Assessed by 6 Minutes Walking Test?
Citation:
European Cardiology Review 2017;12(2):100.
Impact on Patient Care: The 2016 European Heart Failure Guidelines
Citation:
European Cardiology Review 2017;12(2):78–9
Cardiovascular Risk Management Targeting Inflammation in Addition to Lipid-lowering Therapy
Citation:
European Cardiology Review 2017;12(2):88
Influence of Race in the Association of Diabetes and Heart Failure
Citation:
US Cardiology Review 2018;12(1):17–21.
